1. Home
  2. BPMC vs SIRI Comparison

BPMC vs SIRI Comparison

Compare BPMC & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • SIRI
  • Stock Information
  • Founded
  • BPMC 2008
  • SIRI 2013
  • Country
  • BPMC United States
  • SIRI United States
  • Employees
  • BPMC N/A
  • SIRI N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • SIRI Broadcasting
  • Sector
  • BPMC Health Care
  • SIRI Consumer Discretionary
  • Exchange
  • BPMC Nasdaq
  • SIRI Nasdaq
  • Market Cap
  • BPMC 8.3B
  • SIRI 8.1B
  • IPO Year
  • BPMC 2015
  • SIRI 1994
  • Fundamental
  • Price
  • BPMC N/A
  • SIRI $23.58
  • Analyst Decision
  • BPMC Buy
  • SIRI Hold
  • Analyst Count
  • BPMC 18
  • SIRI 14
  • Target Price
  • BPMC $128.87
  • SIRI $26.79
  • AVG Volume (30 Days)
  • BPMC 4.3M
  • SIRI 2.9M
  • Earning Date
  • BPMC 07-31-2025
  • SIRI 07-31-2025
  • Dividend Yield
  • BPMC N/A
  • SIRI 4.58%
  • EPS Growth
  • BPMC N/A
  • SIRI N/A
  • EPS
  • BPMC N/A
  • SIRI N/A
  • Revenue
  • BPMC $562,121,000.00
  • SIRI $8,605,000,000.00
  • Revenue This Year
  • BPMC $44.46
  • SIRI N/A
  • Revenue Next Year
  • BPMC $32.78
  • SIRI N/A
  • P/E Ratio
  • BPMC N/A
  • SIRI N/A
  • Revenue Growth
  • BPMC 99.19
  • SIRI N/A
  • 52 Week Low
  • BPMC $73.04
  • SIRI $18.69
  • 52 Week High
  • BPMC $129.65
  • SIRI $41.20
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 3.63
  • SIRI 51.81
  • Support Level
  • BPMC $129.20
  • SIRI $23.18
  • Resistance Level
  • BPMC $129.65
  • SIRI $24.51
  • Average True Range (ATR)
  • BPMC 0.18
  • SIRI 0.67
  • MACD
  • BPMC -16.40
  • SIRI -0.07
  • Stochastic Oscillator
  • BPMC 0.00
  • SIRI 38.81

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.

About SIRI Sirius XM Holdings Inc.

Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service through a handful of geostationary satellites that it owns and operates; it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.

Share on Social Networks: